Tonix Pharma announced research collaboration to develop precision medicine techniques for COVID-19 vaccines and therapeutics
On Jul. 16, 2020, Tonix Pharmaceuticals announced it had entered into a research collaboration and option agreement with…
WHO and UNICEF warn of a decline in vaccinations during COVID-19
On Jul. 14, 2020, the WHO and UNICEF warned of an alarming decline in the number of children…
More than 150 countries engaged in COVID-19 vaccine global access facility
On Jul. 15, 2020, seventy-five countries submitted expressions of interest to protect their populations and those of other…
Tevogen Bio announced steps toward proprietary T Cell therapy for development of bivalent vaccine for COVID-19 and influenza
On Jul. 15, 2020, Tevogen Bio announced its intention to evaluate its proprietary antigen-specific T cell technology as…
Experimental COVID-19 vaccine safe, generated immune response
On Jul. 14, 2020, an investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus…
Experimental Coronavirus vaccine is safe and produced immune response
On Jul. 14, 2020, NIH researchers reported early results from the first COVID-19 vaccine candidate tested in people…
HKUMed researchers mined immunogenic information from SARS-CoV-2 for rational design of vaccine against SARS-CoV-2
On Jul. 14, 2020, researchers at the The University of Hong Kong (HKUMed) collaborated with researchers at the…
Fosun announced COVID-19 vaccine product received acceptance notice of clinical trial application by NMPA
On Jul. 14, 2020, Shanghai Fosun Pharmaceutical announced it had received the acceptance notice of clinical trial application…
Moderna announced publication in The New England Journal of Medicine of interim results from phase 1 study of its mRNA vaccine against COVID-19
On Jul. 14, 2020, Moderna announced the publication of an interim analysis of the open-label Phase 1 study…
Altimmune and University of Alabama at Birmingham announced positive preclinical results for intranasal COVID-19 vaccine candidate, AdCOVIDï¾™
On Jul. 13, 2020, Altimmune announced positive results from the preclinical studies of its intranasal COVID-19 vaccine candidate,…
Preliminary study suggested tuberculosis vaccine may be limiting COVID-19 deaths
On Jul. 13, 2020, researchers from Virginia Tech and the NIH suggested that Bacille Calmette-Gu�rin (BCG), a tuberculosis…
Spanish National Center for Biotechnology uses Atos supercomputing expertise to find out how Covid-19 virus initiates infection
On Jul. 9, 2020, Atos announced that the Biocomputing Unit at the Spanish National Center for Biotechnology (CNB),…
Moderna and ROVI announced collaboration for OUS fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate
On Jul. 9, 2020 Moderna and Laboratorios Farmaceuticos Rovi announced a collaboration for large-scale, commercial fill-finish manufacturing of…
Altimmune signed agreement with DynPort Vaccine on US Government funding efforts for COVID-19 vaccine candidate, AdCOVIDï¾™
On Jul. 9, 2020, Altimmune announced that it had entered into a teaming agreement with DynPort Vaccine Company…
Kaiser Permanente Washington announced COVID-19 vaccine trial registry opened for volunteers
On Jul. 8, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that it had created a registry…
Moderna completed enrollment of phase 2 study of its mRNA vaccine against COVID-19 (mRNA-1273)
On Jul. 8, 2020 Moderna announced that it had completed enrollment for both cohorts of the Phase 2…
Fred Hutch joined international COVID-19 vaccine effort
On Jul. 8, 2020, the Fred Hutchinson Cancer Research Center was named the coordinating center for vaccine clinical…
GSK and Medicago announced collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
On Jul. 7, 2020, GlaxoSmithKline and Medicago announced a collaboration to develop and evaluate a COVID-19 candidate vaccine…
Novavax announced $1.6 billion funding from Operation Warp Speed
On Jul. 7, 2020, Novavax announced that it has been selected to participate in Operation Warp Speed, a…
Tonix Pharma announced plans for Massachusetts R&D facility to accelerate clinical development of vaccines and protein-based therapeutics
On Jul. 7, 2020, Tonix Pharmaceuticals announced its intent to purchase an approximately 40,000 square foot facility in…
European Investment Bank and EC provided CureVac with $75 million financing for vaccine development and expansion of manufacturing
On Jul. 6, 2020, the European Investment Bank (EIB) and CureVac announced they had entered into a $75…
Sinovac COVID-19 vaccine collaboration with Butantan received approval from Brazilian regulator for phase III trial
On Jul. 6, 2020, Sinovac Biotech announced that on Jul. 3, 2020, the Brazilian National Regulatory Agency, Anvisa,…
Immune Regulation partnered with DynPort Vaccine to advance drug product for COVID-19 into clinical trials
On Jul. 9, 2020, Altimmune announced that it had entered into a teaming agreement with DynPort Vaccine Company…
Emergent BioSolutions signed five-year agreement for large-scale drug substance manufacturing for Johnson & Johnsonï¾’s COVID-19 vaccine candidate
On Jul. 6, 2020, Emergent BioSolutions announced a five-year manufacturing services agreement with Janssen Pharmaceuticals, a Johnson &…
Intravacc in-licensed CimCure’s iBoost technology, expanding its vaccine platform portfolio
On Jul. 1, 2020, Intravacc announced the signing of a strategic partnership agreement with Dutch based CimCure, focusing…
NIH ACTIV vaccine working group weighed role of human challenge studies for SARS-CoV-2 vaccine development
On Jul. 1, 2020, in a Perspective for the New England Journal of Medicine, members of the NIHï¾’s…
Pfizer and BioNTech announced early positive data from ongoing phase 1/2 study of mRNA-based vaccine candidate against SARS-CoV-2
On Jul. 1, 2020, Pfizer and BioNTech announced preliminary data from the most advanced of four investigational vaccine…
Altimmune announces dosing of first patient in phase 1b clinical trial of NasoShieldï¾™ single dose intranasal anthrax vaccine candidate
On Jun. 30, 2020, Altimmune announced dosing of the first patient in the Companyï¾’s Phase 1b clinical trial…
Bharat Biotech COVID-19 vaccine – COVAXINTM received DCGI approval for phase I & II Human clinical trials
On Jun. 29, 2020, Bharat Biotech has successfully developed COVAXINï¾™, Indiaï¾’s 1stvaccine candidate for COVID-19, in collaboration with…
COVID-19 Therapeutics Accelerator donors launched international alliance to connect research data sources and enable collaboration
On Jun. 26, 2020, the COVID-19 Therapeutics Accelerator donors and partners announced the formation of the International COVID-19…